4.8 Article

Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction

期刊

SCIENCE
卷 371, 期 6525, 页码 194-+

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abc0476

关键词

-

资金

  1. NIAID/NIH [R01 AI24493, R21 AI146464, U19 AI109761, R56 AI130130]
  2. NIH [5U24AI116833-02]
  3. Bill and Melinda Gates Foundation [OPP1155863]
  4. Value of Vaccine Research Network grant
  5. Life Sciences Research Foundation
  6. Bill and Melinda Gates Foundation [OPP1155863] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

The study revealed a protective mechanism by simultaneously antagonizing two domains of NS1, providing a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrating the potential of this antibody to treat infections by multiple flaviviruses.
Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the beta-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据